Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 228 citing articles:

Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection
Hans Erik Bøtker, Derek J. Hausenloy, Ioanna Andreadou, et al.
Basic Research in Cardiology (2018) Vol. 113, Iss. 5
Open Access | Times Cited: 372
Circadian rhythms and the molecular clock in cardiovascular biology and disease
Sandra Crnko, Bastiaan C. du Pré, Joost P. G. Sluijter, et al.
Nature Reviews Cardiology (2019) Vol. 16, Iss. 7, pp. 437-447
Closed Access | Times Cited: 361
Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart
Derek J. Hausenloy, David García‐Dorado, Hans Erik Bøtker, et al.
Cardiovascular Research (2017) Vol. 113, Iss. 6, pp. 564-585
Open Access | Times Cited: 313
Extracellular vesicles in diagnostics and therapy of the ischaemic heart: Position Paper from the Working Group on Cellular Biology of the Heart of the European Society of Cardiology
Joost P. G. Sluijter, Sean M. Davidson, Chantal M. Boulanger, et al.
Cardiovascular Research (2017) Vol. 114, Iss. 1, pp. 19-34
Open Access | Times Cited: 306
Cardiac cell–integrated microneedle patch for treating myocardial infarction
Junnan Tang, Jinqiang Wang, Ke Huang, et al.
Science Advances (2018) Vol. 4, Iss. 11
Open Access | Times Cited: 250
Targeted repair of heart injury by stem cells fused with platelet nanovesicles
Junnan Tang, Teng Su, Ke Huang, et al.
Nature Biomedical Engineering (2018) Vol. 2, Iss. 1, pp. 17-26
Open Access | Times Cited: 200
Stem Cell Therapy in Heart Diseases – Cell Types, Mechanisms and Improvement Strategies
Paula Müller, Heiko Lemcke, Robert David
Cellular Physiology and Biochemistry (2018) Vol. 48, Iss. 6, pp. 2607-2655
Open Access | Times Cited: 196
Single-cell transcriptome analyses reveal novel targets modulating cardiac neovascularization by resident endothelial cells following myocardial infarction
Ziwen Li, Emmanouil G Solomonidis, Marco Meloni, et al.
European Heart Journal (2019) Vol. 40, Iss. 30, pp. 2507-2520
Open Access | Times Cited: 181
Melt Electrospinning Writing of Poly‐Hydroxymethylglycolide‐co‐ε‐Caprolactone‐Based Scaffolds for Cardiac Tissue Engineering
Miguel Castilho, Dries Feyen, María Flandes‐Iparraguirre, et al.
Advanced Healthcare Materials (2017) Vol. 6, Iss. 18
Open Access | Times Cited: 178
Melt Electrowriting Allows Tailored Microstructural and Mechanical Design of Scaffolds to Advance Functional Human Myocardial Tissue Formation
Miguel Castilho, Alain van Mil, Malachy Maher, et al.
Advanced Functional Materials (2018) Vol. 28, Iss. 40
Open Access | Times Cited: 165
Advancements in tissue engineering for cardiovascular health: a biomedical engineering perspective
ZahraSadat Razavi, M. Soltani, Golnaz Mahmoudvand, et al.
Frontiers in Bioengineering and Biotechnology (2024) Vol. 12
Open Access | Times Cited: 24
Clinical Studies of Cell Therapy in Cardiovascular Medicine
Monisha N. Banerjee, Roberto Bolli, Joshua M. Hare
Circulation Research (2018) Vol. 123, Iss. 2, pp. 266-287
Open Access | Times Cited: 152
Global position paper on cardiovascular regenerative medicine
Francisco Fernández‐Avilés, Ricardo Sanz-Ruíz, Andreu M. Climent, et al.
European Heart Journal (2017) Vol. 38, Iss. 33, pp. 2532-2546
Open Access | Times Cited: 140
Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial
Bryon A. Tompkins, Darcy L. DiFede, Aisha Khan, et al.
The Journals of Gerontology Series A (2017) Vol. 72, Iss. 11, pp. 1513-1522
Open Access | Times Cited: 133
Translational cardiac stem cell therapy: advancing from first-generation to next-generation cell types
Elena Cambria, Francesco S. Pasqualini, Petra Wolint, et al.
npj Regenerative Medicine (2017) Vol. 2, Iss. 1
Open Access | Times Cited: 129
Epigenomic and transcriptomic approaches in the post-genomic era: path to novel targets for diagnosis and therapy of the ischaemic heart? Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart
Cinzia Perrino, Albert‐László Barabási, Gianluigi Condorelli, et al.
Cardiovascular Research (2017) Vol. 113, Iss. 7, pp. 725-736
Open Access | Times Cited: 116
From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview
Carlo G. Tocchetti, Christian Cadeddu Dessalvi, Daniela Di Lisi, et al.
Antioxidants and Redox Signaling (2017) Vol. 30, Iss. 18, pp. 2110-2153
Open Access | Times Cited: 114
ESC Working Group on Cellular Biology of the Heart: position paper for Cardiovascular Research: tissue engineering strategies combined with cell therapies for cardiac repair in ischaemic heart disease and heart failure
Rosalinda Madonna, Linda W. van Laake, Hans Erik Bøtker, et al.
Cardiovascular Research (2019) Vol. 115, Iss. 3, pp. 488-500
Open Access | Times Cited: 111
Concise Review: Is Cardiac Cell Therapy Dead? Embarrassing Trial Outcomes and New Directions for the Future
Junnan Tang, Jhon Cores, Ke Huang, et al.
Stem Cells Translational Medicine (2018) Vol. 7, Iss. 4, pp. 354-359
Open Access | Times Cited: 109
Carbon nanotube doped pericardial matrix derived electroconductive biohybrid hydrogel for cardiac tissue engineering
Kaveh Roshanbinfar, Zahra Mohammadi, Abdorreza S. Mesgar, et al.
Biomaterials Science (2019) Vol. 7, Iss. 9, pp. 3906-3917
Closed Access | Times Cited: 104
The epicardium as a source of multipotent adult cardiac progenitor cells: Their origin, role and fate
Anke M. Smits, Esther Dronkers, Marie‐José Goumans
Pharmacological Research (2017) Vol. 127, pp. 129-140
Open Access | Times Cited: 103
Endothelial cells release cardioprotective exosomes that may contribute to ischaemic preconditioning
Sean M. Davidson, Jaime A. Riquelme, Ying Zheng, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 98
Next generation of heart regenerative therapies: progress and promise of cardiac tissue engineering
Miguel F. Tenreiro, Ana F. Louro, Paula M. Alves, et al.
npj Regenerative Medicine (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 95
Megakaryocytic Leukemia 1 Bridges Epigenetic Activation of NADPH Oxidase in Macrophages to Cardiac Ischemia-Reperfusion Injury
Liming Yu, Guang Yang, Xinjian Zhang, et al.
Circulation (2018) Vol. 138, Iss. 24, pp. 2820-2836
Open Access | Times Cited: 93
The emerging role of Notch pathway in ageing: Focus on the related mechanisms in age-related diseases
Carmela Rita Balistreri, Rosalinda Madonna, Gerry Melino, et al.
Ageing Research Reviews (2016) Vol. 29, pp. 50-65
Open Access | Times Cited: 87
Page 1 - Next Page

Scroll to top